Contemporary approaches to diagnostics and treatment of nociceptive primary musculoskeletal pain
Open Access
- 23 March 2023
- journal article
- research article
- Published by Alfmed LLC in Medical alphabet
- No. 2,p. 12-18
Abstract
This article discusses contemporary approaches to multimodal, NSAID-sparing management of primary musculoskeletal pain. Despite the scientific advances, musculoskeletal pain remains extremely challenging to manage clinically. While the number of potential treatment targets has grown substantially and a strong case has been made for a mechanism-based and individualized approach to pain therapy, arguably clinicians are not much more advanced now in their capacity to either diagnose or effectively treat patients with musculoskeletal pain. The International Association for the Study of Pain (IASP) pain taxonomy includes pain mechanisms as one of the 3 dimensions that need to be considered when making a diagnostic classification for the concurrent use of separate therapeutic interventions with various mechanisms of action aimed at different pain mechanisms. Combination of shock-wave therapy with topical NSAID tenoxicam is more effective in primary musculoskeletal pain treatment.Keywords
This publication has 17 references indexed in Scilit:
- Systemic Pharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice GuidelineAnnals of Internal Medicine, 2017
- Prevalence of Myofascial Trigger Points in Spinal Disorders: A Systematic Review and Meta-AnalysisArchives of Physical Medicine and Rehabilitation, 2016
- Do we need a third mechanistic descriptor for chronic pain states?Pain, 2016
- Scavenging of photogenerated ROS by Oxicams. Possible biological and environmental implicationsJournal of Photochemistry and Photobiology B: Biology, 2015
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 2015
- Myofascial Trigger Points Then and Now: A Historical and Scientific PerspectivePM&R, 2015
- Oxicams, a class of nonsteroidal anti‐inflammatory drugs and beyondIUBMB Life, 2014
- The chronic pain conundrum: should we CHANGE from relying on past history to assessing prognostic factors?Current Medical Research and Opinion, 2012
- In vitro comparative assessment of the scavenging activity against three reactive oxygen species of non-steroidal anti-inflammatory drugs from the oxicam and sulfoanilide familiesEuropean Journal of Pharmacology, 2004
- In Vitro Effect of Nonsteroidal Antiinflammatory Drugs on Proteoglycanase and Collagenase Activity in Human Osteoarthritic CartilageArthritis & Rheumatism, 1991